A new look at osteoporosis outcomes: The influence of treatment, compliance, persistence, and adherence

被引：21
作者：
Badamgarav, Enkhe [1 ]
Fitzpatrick, Lorraine A. [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
MAYO CLINIC PROCEEDINGS | 2006年 / 81卷 / 08期
关键词：
D O I：
10.4065/81.8.1009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1009 / 1012
页数：4
相关论文
共 27 条
  • [1] Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy
    Björn, I
    Bäckström, T
    [J]. MATURITAS, 1999, 32 (02) : 77 - 86
  • [2] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
    Black, DM
    Cummings, SR
    Karpf, DB
    Cauley, JA
    Thompson, DE
    Nevitt, MC
    Bauer, DC
    Genant, HK
    Haskell, WL
    Marcus, R
    Ott, SM
    Torner, JC
    Quandt, SA
    Reiss, TF
    Ensrud, KE
    [J]. LANCET, 1996, 348 (9041) : 1535 - 1541
  • [3] The impact of compliance with osteoporosis therapy on fracture rates in actual practice
    Caro, JJ
    Ishak, KJ
    Huybrechts, KF
    Raggio, G
    Naujoks, C
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 (12) : 1003 - 1008
  • [4] CAN WE IMPROVE COMPLIANCE WITH LONG-TERM HRT
    COOPE, J
    MARSH, J
    [J]. MATURITAS, 1992, 15 (02) : 151 - 158
  • [5] Persistence with bisphosphonate treatment for osteoporosis: Finding the root of the problem
    Cramer, JA
    Silverman, S
    [J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 (04) : 12S - 17S
  • [6] Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis
    Cramer, JA
    Amonkar, MM
    Hebborn, A
    Altman, R
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (09) : 1453 - 1460
  • [7] Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial
    Delmas, PD
    Ensrud, KE
    Adachi, JD
    Harper, KD
    Sarkar, S
    Gennari, C
    Reginster, JY
    Pols, HAP
    Recker, RR
    Harris, ST
    Wu, WT
    Genant, HK
    Black, DM
    Eastell, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) : 3609 - 3617
  • [8] Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting
    Downey, Timothy W.
    Foltz, Susan H.
    Boccuzzi, Stephen J.
    Omar, Mohamed A.
    Kahler, Kristijan H.
    [J]. SOUTHERN MEDICAL JOURNAL, 2006, 99 (06) : 570 - 575
  • [9] COMPLIANCE WITH LONG-TERM ORAL HORMONAL REPLACEMENT THERAPY
    EIKEN, P
    KOLTHOFF, N
    [J]. MATURITAS, 1995, 22 (02) : 97 - 103
  • [10] Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis
    Harris, ST
    Watts, NB
    Li, Z
    Chines, AA
    Hanley, DA
    Brown, JP
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (05) : 757 - 764
123